Literature DB >> 26507744

Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs.

Siu-Kuen Azor Hui1, Suzanne M Miller2, Leah Hazuda2, Kimberly Engelman3, Edward F Ellerbeck3.   

Abstract

Participation in cancer prevention trials (CPT) is lower than 3 % among high-risk healthy individuals, and racial/ethnic minorities are the most under-represented. Novel recruitment strategies are therefore needed. Online health risk assessment (HRA) serves as a gateway component of nearly all employee wellness programs (EWPs) and may be a missed opportunity. This study aimed to explore employees' interest, willingness, motivators, and barriers of releasing their HRA responses to an external secure research database for recruitment purpose. We used qualitative research methods (focus group and individual interviews) to examine employees' interest and willingness in releasing their online HRA responses to an external, secure database to register as potential CPT participants. Fifteen structured interviews (40 % of study participants were of racial/ethnic minority) were conducted, and responses reached saturation after four interviews. All employees showed interest and willingness to release their online HRA responses to register as a potential CPT participant. Content analyses revealed that 91 % of participants were motivated to do so, and the major motivators were to (1) obtain help in finding personally relevant prevention trials, (2) help people they know who are affected by cancer, and/or (3) increase knowledge about CPT. A subset of participants (45 %) expressed barriers of releasing their HRA responses due to concerns about credibility and security of the external database. Online HRA may be a feasible but underutilized recruitment method for cancer prevention trials. EWP-sponsored HRA shows promise for the development of a large, centralized registry of racially/ethnically representative CPT potential participants.

Entities:  

Keywords:  Cancer clinical trials; Cancer prevention trials; Cancer risk registry; Clinical trial recruitment; Electronic health data transfer; Employee wellness program; Health communication; Online health risk assessment; Recruitment strategy

Mesh:

Year:  2016        PMID: 26507744      PMCID: PMC4848180          DOI: 10.1007/s13187-015-0927-8

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  19 in total

1.  An ethno-medical perspective on research participation: a qualitative pilot study.

Authors:  José L Calderón; Richard S Baker; Horacio Fabrega; José G Conde; Ron D Hays; Erik Fleming; Keith Norris
Journal:  MedGenMed       Date:  2006-04-25

Review 2.  Latino recruitment to cancer prevention/screening trials in the Southwest: setting a research agenda.

Authors:  Linda K Larkey; Sheryl L Ogden; Sally Tenorio; Teresa Ewell
Journal:  Appl Nurs Res       Date:  2008-02       Impact factor: 2.257

Review 3.  Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

Authors:  Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

Review 4.  An 'Honest Broker' mechanism to maintain privacy for patient care and academic medical research.

Authors:  Andrew D Boyd; Charlie Hosner; Dale A Hunscher; Brian D Athey; Daniel J Clauw; Lee A Green
Journal:  Int J Med Inform       Date:  2006-11-01       Impact factor: 4.046

5.  Recruitment strategies for cervical cancer prevention study.

Authors:  W R Brewster; H Anton-Culver; A Ziogas; J Largent; S Howe; F A Hubbell; A Manetta
Journal:  Gynecol Oncol       Date:  2002-05       Impact factor: 5.482

6.  The University of Michigan Honest Broker: a Web-based service for clinical and translational research and practice.

Authors:  Andrew D Boyd; Paul R Saxman; Dale A Hunscher; Kevin A Smith; Timothy D Morris; Michelle Kaston; Frederick Bayoff; Bruce Rogers; Pamela Hayes; Namrata Rajeev; Eva Kline-Rogers; Kim Eagle; Daniel Clauw; John F Greden; Lee A Green; Brian D Athey
Journal:  J Am Med Inform Assoc       Date:  2009-08-28       Impact factor: 4.497

7.  Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans.

Authors:  S Millon-Underwood; E Sanders; M Davis
Journal:  Cancer Nurs       Date:  1993-02       Impact factor: 2.592

8.  Participation in cancer clinical trials: why are patients not participating?

Authors:  Margaret M Byrne; Stacey L Tannenbaum; Stefan Glück; Judith Hurley; Michael Antoni
Journal:  Med Decis Making       Date:  2013-07-29       Impact factor: 2.583

9.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

10.  An examination of community members', researchers' and health professionals' perceptions of barriers to minority participation in medical research: an application of concept mapping.

Authors:  JaMuir M Robinson; William M K Trochim
Journal:  Ethn Health       Date:  2007-11       Impact factor: 2.772

View more
  2 in total

1.  A Framework for Equitable Partnerships to Promote Cancer Prevention and Control in Rural Settings.

Authors:  Linda K Ko; Isabel C Scarinci; Elizabeth G Bouchard; Bettina F Drake; Elisa M Rodriguez; Moon S Chen; Deanna Kepka; Aaron J Kruse-Diehr; Christie Befort; Jackilen Shannon; Paige E Farris; Amy Trentham-Dietz; Tracy Onega
Journal:  JNCI Cancer Spectr       Date:  2022-03-02

2.  Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.

Authors:  Catherine Houghton; Maura Dowling; Pauline Meskell; Andrew Hunter; Heidi Gardner; Aislinn Conway; Shaun Treweek; Katy Sutcliffe; Jane Noyes; Declan Devane; Jane R Nicholas; Linda M Biesty
Journal:  Cochrane Database Syst Rev       Date:  2020-10-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.